|
|
Volumn 46, Issue 3, 2002, Pages 904-908
|
|
In vitro antibacterial activities of DQ-113, a potent quinolone, against clinical isolates
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CIPROFLOXACIN;
DQ 113;
GARENOXACIN;
GATIFLOXACIN;
GEMIFLOXACIN;
HABEKACIN;
IMIPENEM;
LEVOFLOXACIN;
LINEZOLID;
MINOCYCLINE;
MOXIFLOXACIN;
OXACILLIN;
QUINOLONE DERIVATIVE;
SITAFLOXACIN;
SPARFLOXACIN;
TEICOPLANIN;
TOSUFLOXACIN;
UNCLASSIFIED DRUG;
VANCOMYCIN;
ANTIBACTERIAL ACTIVITY;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
BACTERIAL INFECTION;
BACTERIUM ISOLATION;
COLONY FORMING UNIT;
DRUG POTENCY;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MINIMUM INHIBITORY CONCENTRATION;
MULTIDRUG RESISTANCE;
NONHUMAN;
PRIORITY JOURNAL;
SPECIES DIFFERENTIATION;
STRAIN DIFFERENCE;
ANTI-INFECTIVE AGENTS;
BACTERIA;
BACTERIAL INFECTIONS;
DRUG RESISTANCE, MICROBIAL;
DRUG RESISTANCE, MULTIPLE;
FLUOROQUINOLONES;
GRAM-NEGATIVE BACTERIA;
GRAM-POSITIVE BACTERIA;
MICROBIAL SENSITIVITY TESTS;
QUINOLONES;
|
|
EID: 0036173450
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.46.3.904-908.2002 Document Type: Article |
|
Times cited : (21)
|
|
References (11)
|
